News
2020.02.04
The examiner’s assessment in Japan has been issued to the patent application for “Immunological biomarker for predicting clinical effect of cancer immunotherapy” filed by Saitama Medical University.
More
2020.01.16
New Location
More
2019.07.16
Our officer personnel affairs
More
2018.08.08
ImmuniT Research Inc. will participate in BioJapan 2018.
More
2018.04.04
ImmuniT Research Inc. has signed a license agreement with “Sysmex Corporation” regarding exclusive rights that anticipates the effect of immuno-checkpoint inhibitors by blood test.
More
2017.09.25
Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation
More